Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib ; volume:19 ; number:1 ; day:1 ; month:4 ; year:2019 ; pages:1-13 ; date:12.2019
BMC cancer ; 19, Heft 1 (1.4.2019), 1-13, 12.2019
- Urheber
-
Oh, Chung Ryul
Kong, Sun-Young
Im, Hyeon-Su
Kim, Hwa Jung
Kim, Min Kyeong
Yoon, Kyong-Ah
Cho, Eun-Hae
Jang, Ja-Hyun
Lee, Junnam
Kang, Jihoon
Park, Sook Ryun
Ryoo, Baek-Yeol
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-019-5483-x
- URN
-
urn:nbn:de:101:1-2019042200462918383745
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Oh, Chung Ryul
- Kong, Sun-Young
- Im, Hyeon-Su
- Kim, Hwa Jung
- Kim, Min Kyeong
- Yoon, Kyong-Ah
- Cho, Eun-Hae
- Jang, Ja-Hyun
- Lee, Junnam
- Kang, Jihoon
- Park, Sook Ryun
- Ryoo, Baek-Yeol
- SpringerLink (Online service)
Ähnliche Objekte (12)
LABS: linear amplification-based bisulfite sequencing for ultrasensitive cancer detection from cell-free DNA
Sorafenib : Sorafenib in der Behandlung des Radiojod-refraktären differenzierten Schilddrüsenkarzinoms
Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration
Optimierung der Sorafenib-Therapie
Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder
Whole genome amplification of cell-free DNA enables detection of circulating tumor DNA mutations from fingerstick capillary blood
Publisher Correction: Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration
Sorafenib-Induced Capillary Leak Syndrome
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo
Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma
Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells
Sorafenib : aktuelle Therapieoptionen bei hepatozellulärem Karzinom
LABS: linear amplification-based bisulfite sequencing for ultrasensitive cancer detection from cell-free DNA
Sorafenib : Sorafenib in der Behandlung des Radiojod-refraktären differenzierten Schilddrüsenkarzinoms
Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration
Optimierung der Sorafenib-Therapie
Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder
Whole genome amplification of cell-free DNA enables detection of circulating tumor DNA mutations from fingerstick capillary blood
Publisher Correction: Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration
Sorafenib-Induced Capillary Leak Syndrome
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo
Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma
Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells
Sorafenib : aktuelle Therapieoptionen bei hepatozellulärem Karzinom
LABS: linear amplification-based bisulfite sequencing for ultrasensitive cancer detection from cell-free DNA
Sorafenib : Sorafenib in der Behandlung des Radiojod-refraktären differenzierten Schilddrüsenkarzinoms
Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration
Optimierung der Sorafenib-Therapie
Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder
Whole genome amplification of cell-free DNA enables detection of circulating tumor DNA mutations from fingerstick capillary blood
Publisher Correction: Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration
Sorafenib-Induced Capillary Leak Syndrome
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo
Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma
Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells